Pharmafile Logo

wearable technologies

Roche Basel Switzerland

Roche’s autism drug scores FDA breakthrough status

Balovaptan could become the first drug to treat autism spectrum disorder

- PMLiVE

Shire separates out neuroscience as it considers its future

Follows last year's strategic review at the Irish biotechnology firm

- PMLiVE

Akili to submit video game ADHD treatment for US approval in 2018

Follows trial suggesting attention benefits of its 'digital medicine' AKL-T01

Eisai launches location tracker for dementia patients

Collaborates with Japanese smartphone app network Mamorio on the new tool

- PMLiVE

Tools for the digital world

The next step for the pharma industry

Mental health in the workplace

Mental health in the workplace

One in five people in the workplace will experience a mental health condition. Learn to spot the signs and the steps that you can take to care for yourself and...

Porterhouse Medical Group

- PMLiVE

HCA looks for mental health ‘champions’ in healthcare communications

Marks World Mental Health day with community group partnership

- PMLiVE

Egg launches wearable patient insight experience ‘Virtual Mile’

The Virtual Mile glasses will pair with an app and make audio and visual recordings

- PMLiVE

Sanofi looks to mobile data to power behavioural analysis

Teams up with Evidation Health for a new digital health partnership

- PMLiVE

Could ketamine be the next big thing in depression?

Account Executive Will Frostick discusses the established treatment model for depression and its limitations, as well as a new entrant poised to revolutionise the field – ketamine.

Blue Latitude Health

- PMLiVE

Denny Bros team up with artist to support mental health charity

The specialist print group donates £2,000 to Suffolk Mind

Sanofi: Wearables are a core part of our digital trials strategy

Pharma firm partners with Parexel on patient sensor work

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links